Target intelligence / Profile preview

MDC1 antisense RNA 1 (MDC1-AS1)

Target
MDC1-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

MDC1 antisense RNA 1 (MDC1-AS1) is a long noncoding antisense RNA transcribed from the opposite strand of the MDC1 gene, which encodes the mediator of DNA damage checkpoint protein 1[3][2]. MDC1-AS1 has been identified as downregulated in various human cancers, including bladder cancer, gastric cancer, and glioma[3][2][5]. The RNA positively regulates its sense coding gene MDC1, known for its role as a tumor suppressor and crucial mediator of the DNA damage response[2][1][3]. Overexpression of MDC1-AS1 leads to increased MDC1 mRNA and protein levels, resulting in suppressed proliferation, migration, and invasion of cancer cells[3][1]. The tumor-suppressive effect of MDC1-AS1 appears to be mediated via upregulation of MDC1; when MDC1 is knocked down, the inhibitory effect of MDC1-AS1 on tumor cell behavior is lost[3][1]. Although MDC1-AS1 is implicated in cancer biology, it is not a receptor, enzyme, or other traditional therapeutic target molecule, but is rather an antisense lncRNA that may regulate the expression of a tumor suppressor gene[3][2][1][5].

Other names
MDC1-ASMDC1 antisense RNA 1 (non-protein coding)XXbac-BPG27H4.7MDC1-AS1
02

Biological functions

Regulation of gene expressionPositive regulation of MDC1 (Mediator of DNA damage checkpoint protein 1)Tumor suppression via modulation of DNA damage response
03

Disease associations

Cancer (notably bladder cancer, gastric cancer, glioma)

Beyond the preview

Go deeper on MDC1 antisense RNA 1 (MDC1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDC1 antisense RNA 1 (MDC1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call